AL
EMN icon

Aspiriant LLC’s Eastman Chemical EMN Stock Holding History

Aspiriant LLC’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,364
Closed -$226K – 232
2018
Q3 		$226K Hold
2,364
– – 0.02% 216
2018
Q2 		$236K Hold
2,364
– – 0.02% 225
2018
Q1 		$250K Buy
+2,364
New +$239K 0.02% 210
2017
Q4 		– Sell
-2,364
Closed -$214K – 108
2017
Q3 		$214K Buy
+2,364
New +$201K 0.02% 190

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Aspiriant LLC's EMN Position: Q4 2018 in Review

Aspiriant LLC sold out of Eastman Chemical (EMN) in Q4 2018, closing a stake of 2,364 shares — an estimated $226K sold.

Aspiriant LLC first reported a position in EMN in Q3 2017 and held it in 4 quarters. The position peaked at $250K in Q1 2018. 688 funds tracked by Wall St. Rank hold EMN as of Q4 2018.

  • Aspiriant LLC reported no remaining Eastman Chemical position as of Q4 2018 after selling out during the quarter.
  • Aspiriant LLC sold 2,364 Eastman Chemical shares in Q4 2018, an estimated $226K.
  • Aspiriant LLC first reported a position in Eastman Chemical in Q3 2017 and held it in 4 quarters.
  • Aspiriant LLC's Eastman Chemical position peaked at $250K in Q1 2018.
  • 688 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2018.

Based on Aspiriant LLC's 13F filing for Q4 2018, filed 4 Feb 2019.